Serrero G, Lepak N M, Hayashi J, Eisinger D P
W. Alton Jones Cell Science Center, Inc., Lake Placid, New York 12946.
Cancer Res. 1992 Aug 1;52(15):4242-7.
1246-3A is an insulin-independent tumorigenic cell line isolated from the C3H mouse teratoma-derived adipogenic cell line 1246. In the present paper, we have demonstrated that testosterone inhibits the in vivo tumorigenic properties of the 1246-3A cells. Castrated male mice receiving injections of 1246-3A cells developed larger tumors at a higher frequency than sham-operated animals. Administration of testosterone to castrated male mice resulted in a dramatic decrease in tumor development. In vitro studies indicated that testosterone inhibited by 50% the proliferation of the 1246-3A cells in culture. However, growth inhibition was observed only if the cells had been cultivated in the presence of testosterone for at least 4 days. In contrast, testosterone had little effect on the proliferation of the parent cell line 1246. Binding of several polypeptide growth factors was examined in cells cultivated in the absence and in the presence of testosterone. Testosterone increased 125I-EGF specific binding to 1246-3A cells. Scatchard analysis of EGF binding indicated that testosterone treatment induced a 2.4-fold increase in the number of cell surface EGF binding sites. This was accompanied by an increase in the intensity of cross-linked EGF receptors on the cells treated with testosterone. In addition, 1246-3A cells cultivated for 9 days in the presence of testosterone displayed a 10-fold increase in the level of EGF receptor mRNA when compared to 1246-3A cells maintained in its absence. Similar to its action on cell proliferation, the increase in EGF receptor number and mRNA expression was observed mainly if 1246-3A cells had been exposed to testosterone for 9 days. The data presented in this paper demonstrate that both in vivo and in vitro, testosterone induces in the teratoma-derived 1246-3A cell line phenotypic changes such as growth inhibition and modulation of EGF receptor expression.
1246 - 3A是一种从C3H小鼠畸胎瘤来源的脂肪生成细胞系1246中分离出的不依赖胰岛素的致瘤细胞系。在本文中,我们已经证明睾酮可抑制1246 - 3A细胞的体内致瘤特性。接受1246 - 3A细胞注射的去势雄性小鼠比假手术动物更频繁地长出更大的肿瘤。给去势雄性小鼠施用睾酮导致肿瘤发生显著减少。体外研究表明,睾酮可抑制培养的1246 - 3A细胞增殖50%。然而,只有当细胞在睾酮存在下培养至少4天时才观察到生长抑制。相比之下,睾酮对亲本细胞系1246的增殖几乎没有影响。在不存在和存在睾酮的情况下培养的细胞中检测了几种多肽生长因子的结合情况。睾酮增加了125I - EGF与1246 - 3A细胞的特异性结合。对EGF结合的Scatchard分析表明,睾酮处理使细胞表面EGF结合位点的数量增加了2.4倍。这伴随着用睾酮处理的细胞上交联的EGF受体强度的增加。此外,与在不存在睾酮的情况下培养的1246 - 3A细胞相比,在睾酮存在下培养9天的1246 - 3A细胞的EGF受体mRNA水平增加了10倍。与其对细胞增殖的作用类似,主要在1246 - 3A细胞暴露于睾酮9天时才观察到EGF受体数量和mRNA表达的增加。本文提供的数据表明,无论在体内还是体外,睾酮都会在畸胎瘤来源的1246 - 3A细胞系中诱导表型变化,如生长抑制和EGF受体表达的调节。